SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-016427
Filing Date
2022-03-04
Accepted
2022-03-04 17:28:48
Documents
2
Period of Report
2022-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1610
2 POA DOCUMENT poa.txt EX-24 3863
  Complete submission text file 0001209191-22-016427.txt   7034
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 SPEAR STREET, THIRD FLOOR SAN FRANCISCO CA 94105
Business Address
PALEKAR ROHAN (Reporting) CIK: 0001423327 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36327 | Film No.: 22715398